Evidence map›Paper›PMID 35887183›Full record

ReviewInternational journal of molecular sciences2022

T-Cell Intracellular Antigen 1-Like Protein in Physiology and Pathology.

Beatriz Ramos Velasco, José M Izquierdo

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Beatriz Ramos VelascoSevero Ochoa Molecular Biology Center, Spanish National Research Council, Autonomous University of Madrid (CSIC/UAM), 28049 Madrid, Spain.
José M IzquierdoSevero Ochoa Molecular Biology Center, Spanish National Research Council, Autonomous University of Madrid (CSIC/UAM), 28049 Madrid, Spain.ORCID 0000-0002-7942-4046

Funding

Ministerio de Ciencia e Innovación and Agencia Española de Investigación through FEDER funds (RTI2018-098517-B100 and PID2021-126152OB-100) (MICINN/AEI/FEDER, UE). The CBMSO receives an institutional grant from Fundación Ramón Areces and Banco de Santande RTI2018-098517-B100 and PID2021-126152OB-100 (MICINN/AEI/FEDER, UE)
6 · The paper itself

Abstract

T-cell intracellular antigen 1 (TIA1)-related/like (TIAR/TIAL1) protein is a multifunctional RNA-binding protein (RBP) involved in regulating many aspects of gene expression, independently or in combination with its paralog TIA1. TIAR was first described in 1992 by Paul Anderson's lab in relation to the development of a cell death phenotype in immune system cells, as it possesses nucleolytic activity against cytotoxic lymphocyte target cells. Similar to TIA1, it is characterized by a subcellular nucleo-cytoplasmic localization and ubiquitous expression in the cells of different tissues of higher organisms. In this paper, we review the relevant structural and functional information available about TIAR from a triple perspective (molecular, cellular and pathophysiological), paying special attention to its expression and regulation in cellular events and processes linked to human pathophysiology.

Indexed as

RNA-Binding ProteinsT-LymphocytesCytoplasmHumansT-Cell Intracellular Antigen-1RNA-Binding ProteinsT-Cell Intracellular Antigen-1TIAL1 protein, humancellular homeostasisgene expressionpathophysiologyTIAL1TIAR

Identifiers

PMID35887183
PMCPMC9318959

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.